Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

INmune Bio Inc (0Y2.BE)

6.25
0.00
(0.00%)
At close: 9:52:06 PM GMT+2
Loading Chart for 0Y2.BE
  • Previous Close 6.25
  • Open 6.25
  • Bid 6.20 x --
  • Ask 6.45 x --
  • Day's Range 6.15 - 7.05
  • 52 Week Range 4.20 - 10.60
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0Y2.BE

View More

Performance Overview: 0Y2.BE

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

0Y2.BE
36.46%
S&P 500 (^GSPC)
4.26%

1-Year Return

0Y2.BE
41.04%
S&P 500 (^GSPC)
8.55%

3-Year Return

0Y2.BE
11.35%
S&P 500 (^GSPC)
36.57%

5-Year Return

0Y2.BE
39.90%
S&P 500 (^GSPC)
95.45%

Compare To: 0Y2.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0Y2.BE

View More

Valuation Measures

As of 5/6/2025
  • Market Cap

    144.87M

  • Enterprise Value

    126.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.07k

  • Price/Book (mrq)

    5.06

  • Enterprise Value/Revenue

    10.24k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0Y2.BE

View More